Non-Secreted Clusterin Isoforms Are Translated in Rare Amounts from Distinct Human mRNA Variants and Do Not Affect Bax-Mediated Apoptosis or the NF-κB Signaling Pathway

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Prochnow, Hans ^a   Gollan, Rene ^b   Rohne, Philipp ^a   Hassemer, Matthias ^a   Koch Brandt, Claudia ^a   Baiersdörfer, Markus ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CLUSTERIN; CLUSTERIN[1-449]; CLUSTERIN[21-449]; CLUSTERIN[34-449]; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; NON SECRETED CLUSTERIN ISOFORM; PROTEASOME; PROTEIN BAX; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL STRESS; CLUSTERIN GENE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EXON; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; MALE; MUTAGENESIS; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; RNA SPLICING; RNA TRANSLATION; START CODON; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TRANSLATION INITIATION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CACO-2 CELLS; CELL PROLIFERATION; CLUSTERIN; HEK293 CELLS; HUMANS; IMMUNOENZYME TECHNIQUES; LUCIFERASES; MCF-7 CELLS; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84884476384     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075303     Document Type: Article

References (70)

1. Calero M, Rostagno A, Frangione B, Ghiso J, (2005) Clusterin and Alzheimer's disease. Subcell Biochem 38: 273-298. doi:10.1007/0-387-23226-5_14. PubMed: 15709484.
2. Nuutinen T, Suuronen T, Kauppinen A, Salminen A, (2009) Clusterin: a forgotten player in Alzheimer's disease. Brain. Res Rev 61: 89-104. doi:10.1016/j.brainresrev.2009.05.007.
3. Kempster S, Collins ME, Aronow BJ, Simmons M, Green RB, et al. (2004) Clusterin shortens the incubation and alters the histopathology of bovine spongiform encephalopathy in mice. Neuroreport 15: 1735-1738. doi:10.1097/01.wnr.0000134990.97051.22. PubMed: 15257138.
4. Han BH, DeMattos RB, Dugan LL, Kim-Han JS, Brendza RP, et al. (2001) Clusterin contributes to caspase-3-independent brain injury following neonatal hypoxia-ischemia. Nat Med 7: 338-343. doi:10.1038/85487. PubMed: 11231633.
5. Van Dijk A, Vermond RA, Krijnen PA, Juffermans LJ, Hahn NE, et al. (2010) Intravenous clusterin administration reduces myocardial infarct size in rats. Eur J Clin Invest 40: 893-902. doi:10.1111/j.1365-2362.2010.02345.x. PubMed: 20854280.
6. McLaughlin L, Zhu G, Mistry M, Ley-Ebert C, Stuart WD, et al. (2000) Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. J Clin Invest 106: 1105-1113. doi:10.1172/JCI9037. PubMed: 11067863.
7. Schwarz M, Spath L, Lux CA, Paprotka K, Torzewski M, et al. (2008) Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity. Thromb Haemost 100: 110-118.
8. Kim HJ, Yoo EK, Kim JY, Choi YK, Lee HJ, et al. (2009) Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells. Arterioscler Thromb Vasc Biol 29: 1558-1564.
9. Zoubeidi A, Gleave M, (2012) Small heat shock proteins in cancer therapy and prognosis. Int J Biochem Cell Biol, 44: 1646-56. PubMed: 22571949.
10. Trougakos IP, Gonos ES, (2009) Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicalschapter 9. Adv Cancer Res 104: 171-210. doi:10.1016/S0065-230X(09)04009-3. PubMed: 19878777.
11. Richter K, Haslbeck M, Buchner J, (2010) The heat shock response: life on the verge of death. Mol Cell 40: 253-266. doi:10.1016/j.molcel.2010.10.006. PubMed: 20965420.
12. Wong P, Taillefer D, Lakins J, Pineault J, Chader G, et al. (1994) Molecular characterization of human TRPM-2/clusterin, a gene associated with sperm maturation, apoptosis and neurodegeneration. Eur J Biochem 221: 917-925. doi:10.1111/j.1432-1033.1994.tb18807.x. PubMed: 8181474.
13. Gutacker C, Klock G, Diel P, Koch-Brandt C, (1999) Nerve growth factor and epidermal growth factor stimulate clusterin gene expression in PC12 cells. Biochem J 339(3):: 759-766. doi:10.1042/0264-6021:3390759. PubMed: 10215617.
14. Schepeler T, Mansilla F, Christensen LL, Orntoft TF, Andersen CL, (2007) Clusterin expression can be modulated by changes in TCF1-mediated Wnt signaling. J Mol Signal 2: 6. doi:10.1186/1750-2187-2-6. PubMed: 17634137.
15. Sala A, Bettuzzi S, Pucci S, Chayka O, Dews M, et al. (2009) Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis. Adv Cancer Res 105: 115-132. doi:10.1016/S0065-230X(09)05007-6. PubMed: 19879426.
16. Viard I, Wehrli P, Jornot L, Bullani R, Vechietti JL, et al. (1999) Clusterin gene expression mediates resistance to apoptotic cell death induced by heat shock and oxidative stress. J Invest Dermatol 112: 290-296. doi:10.1046/j.1523-1747.1999.00531.x. PubMed: 10084304.
17. Michel D, Chatelain G, North S, Brun G, (1997) Stress-induced transcription of the clusterin/apoJ gene. Biochem J 328(1):: 45-50. PubMed: 9359832.
18. Loison F, Debure L, Nizard P, le Goff P, Michel D, et al. (2006) Up-regulation of the clusterin gene after proteotoxic stress: implication of HSF1-HSF2 heterocomplexes. Biochem J 395: 223-231. doi:10.1042/BJ20051190. PubMed: 16336210.
19. Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR, (1999) Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 274: 6875-6881. doi:10.1074/jbc.274.11.6875. PubMed: 10066740.
20. Carver JA, Rekas A, Thorn DC, Wilson MR, (2003) Small heat-shock proteins and clusterin: intra- and extracellular molecular chaperones with a common mechanism of action and function? IUBMB Life 55: 661-668. doi:10.1080/15216540310001640498. PubMed: 14769002.
21. Bartl MM, Luckenbach T, Bergner O, Ullrich O, Koch-Brandt C, (2001) Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes. Exp Cell Res 271: 130-141. doi:10.1006/excr.2001.5358. PubMed: 11697889.
22. Baiersdörfer M, Schwarz M, Seehafer K, Lehmann C, Heit A, et al. (2010) Toll-like receptor 3 mediates expression of clusterin/apolipoprotein J in vascular smooth muscle cells stimulated with RNA released from necrotic cells. Exp Cell Res 316: 3489-3500.
23. Ammar H, Closset JL, (2008) Clusterin activates survival through the phosphatidylinositol 3-kinase/Akt pathway. J Biol Chem 283: 12851-12861. doi:10.1074/jbc.M800403200. PubMed: 18321852.
24. Dumont P, Chainiaux F, Eliaers F, Petropoulou C, Remacle J, et al. (2002) Overexpression of apolipoprotein J in human fibroblasts protects against cytotoxicity and premature senescence induced by ethanol and tert-butylhydroperoxide. Cell Stress Chaperones 7: 23-35.
25. Miyake H, Hara I, Gleave ME, Eto H, (2004) Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen. Prostate 61: 318-323. doi:10.1002/pros.20087. PubMed: 15389725.
26. Trougakos IP, Lourda M, Agiostratidou G, Kletsas D, Gonos ES, (2005) Differential effects of clusterin/apolipoprotein J on cellular growth and survival. Free Radic Biol Med 38: 436-449.
27. Redondo M, Téllez T, Roldan MJ, Serrano A, García-Aranda M, et al. (2007) Anticlusterin treatment of breast cancer cells increases the sensitivities of chemotherapy and tamoxifen and counteracts the inhibitory action of dexamethasone on chemotherapy-induced cytotoxicity. Breast Cancer Res 9: R86. doi:10.1186/bcr1835. PubMed: 18078515.
28. So A, Sinnemann S, Huntsman D, Fazli L, Gleave M, (2005) Knockdown of the cytoprotective chaperone, clusterin, chemosensitizes human breast cancer cells both in vitro and in vivo. Mol Cancer Ther 4: 1837-1849. doi:10.1158/1535-7163.MCT-05-0178. PubMed: 16373699.
29. Trougakos IP, So A, Jansen B, Gleave ME, Gonos ES, (2004) Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 64: 1834-1842. doi:10.1158/0008-5472.CAN-03-2664. PubMed: 14996747.
30. Thomas-Tikhonenko A, Viard-Leveugle I, Dews M, Wehrli P, Sevignani C, et al. (2004) Myc-transformed epithelial cells down-regulate clusterin, which inhibits their growth in vitro and carcinogenesis in vivo. Cancer Res 64: 3126-3136. doi:10.1158/0008-5472.CAN-03-1953. PubMed: 15126350.
31. Bettuzzi S, Scorcioni F, Astancolle S, Davalli P, Scaltriti M, et al. (2002) Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene 21: 4328-4334. doi:10.1038/sj.onc.1205594. PubMed: 12082621.
32. Nizard P, Tetley S, Le Drean Y, Watrin T, Le Goff P, et al. (2007) Stress-induced retrotranslocation of clusterin/ApoJ into the cytosol. Traffic 8: 554-565. doi:10.1111/j.1600-0854.2007.00549.x. PubMed: 17451556.
33. Li N, Zoubeidi A, Beraldi E, Gleave ME, (2012) GRP78 regulates clusterin stability, retrotranslocation and mitochondrial localization under ER stress in prostate cancer. Oncogene, 32: 1933-42. PubMed: 22689054.
34. Moretti RM, Marelli MM, Mai S, Cariboni A, Scaltriti M, et al. (2007) Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis. Cancer Res 67: 10325-10333. doi:10.1158/0008-5472.CAN-07-0516. PubMed: 17974975.
35. Reddy KB, Jin G, Karode MC, Harmony JA, Howe PH, (1996) Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells. Biochemistry 35: 6157-6163. doi:10.1021/bi952981b. PubMed: 8634259.
36. Rizzi F, Coletta M, Bettuzzi S, (2009) Clusterin (CLU): From one gene and two transcripts to many proteinschapter 2. Adv Cancer Res 104: 9-23. doi:10.1016/S0065-230X(09)04002-0. PubMed: 19878770.
37. Bettuzzi S, Rizzi F, (2009) Nuclear CLU (nCLU) and the fate of the cellchapter 5. Adv Cancer Res 104: 59-88. doi:10.1016/S0065-230X(09)04005-6. PubMed: 19878773.
38. Leskov KS, Araki S, Lavik JP, Gomez JA, Gama V, et al. (2011) CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor. J Biol Chem 286: 40083-40090. doi:10.1074/jbc.M111.252957. PubMed: 21953454.
39. Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA, (2003) Synthesis and functional analysis of nuclear clusterin, a cell death protein. J Biol Chem 278: 11590-11600. doi:10.1074/jbc.M209233200. PubMed: 12551933.
40. Scaltriti M, Santamaria A, Paciucci R, Bettuzzi S, (2004) Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1. Cancer Res 64: 6174-6182. doi:10.1158/0008-5472.CAN-04-0920. PubMed: 15342402.
41. Trougakos IP, Lourda M, Antonelou MH, Kletsas D, Gorgoulis VG, et al. (2009) Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin Cancer Res 15: 48-59. doi:10.1158/1078-0432.CCR-08-1805. PubMed: 19118032.
42. Zhang H, Kim JK, Edwards CA, Xu Z, Taichman R, et al. (2005) Clusterin inhibits apoptosis by interacting with activated Bax. Nat Cell Biol 7: 909-915. doi:10.1038/ncb1291. PubMed: 16113678.
43. Kim N, Yoo JC, Han JY, Hwang EM, Kim YS, et al. (2011) Human nuclear clusterin mediates apoptosis by interacting with Bcl-XL through C-terminal coiled coil domain. J Cell Physiol 227: 1157-1167. PubMed: 21567405.
44. Santilli G, Aronow BJ, Sala A, (2003) Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity. J Biol Chem 278: 38214-38219.
45. Zoubeidi A, Ettinger S, Beraldi E, Hadaschik B, Zardan A, et al. (2010) Clusterin facilitates COMMD1 and I-kappaB degradation to enhance NF-kappaB activity in prostate cancer cells. Mol Cancer Res 8: 119-130. doi:10.1158/1541-7786.MCR-09-0277. PubMed: 20068069.
46. Laskin JJ, Nicholas G, Lee C, Gitlitz B, Vincent M, et al. (2011) Phase I/II trial of custirsen (OGX-011), an inhibitor of clusterin, in combination with a gemcitabine and platinum regimen in patients with previously untreated advanced non-small cell lung cancer. J Thorac Oncol 7: 579-586. PubMed: 22198426.
47. Wehrli P, Charnay Y, Vallet P, Zhu G, Harmony J, et al. (2001) Inhibition of post-ischemic brain injury by clusterin overexpression. Nat Med 7: 977-979. doi:10.1038/nm0901-977. PubMed: 11533682.
48. Imhof A, Charnay Y, Vallet PG, Aronow B, Kovari E, et al. (2006) Sustained astrocytic clusterin expression improves remodeling after brain ischemia. Neurobiol Dis 22: 274-283. doi:10.1016/j.nbd.2005.11.009. PubMed: 16473512.
49. Bell RD, Sagare AP, Friedman AE, Bedi GS, Holtzman DM, et al. (2007) Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab 27: 909-918. PubMed: 17077814.
50. DeMattos RB, O'Dell MA, Parsadanian M, Taylor JW, Harmony JA, et al. (2002) Clusterin promotes amyloid plaque formation and is critical for neuritic toxicity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 99: 10843-10848. doi:10.1073/pnas.162228299. PubMed: 12145324.
51. Hamada N, Miyata M, Eto H, Ikeda Y, Shirasawa T, et al. (2011) Loss of clusterin limits atherosclerosis in apolipoprotein E-deficient mice via reduced expression of Egr-1 and TNF-alpha. J Atheroscler Thromb 18: 209-216. doi:10.5551/jat.5819. PubMed: 21099169.
52. Zoubeidi A, Chi K, Gleave M, (2010) Targeting the cytoprotective chaperone, clusterin, for treatment of advanced cancer. Clin Cancer Res 16: 1088-1093. doi:10.1158/1078-0432.CCR-09-2917. PubMed: 20145158.
53. Bettuzzi S, Davalli P, Davoli S, Chayka O, Rizzi F, et al. (2009) Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread. Oncogene 28: 4344-4352. doi:10.1038/onc.2009.286. PubMed: 19784068.
54. Rizzi F, Caccamo AE, Belloni L, Bettuzzi S, (2009) Clusterin is a short half-life, poly-ubiquitinated protein, which controls the fate of prostate cancer cells. J Cell Physiol 219: 314-323. doi:10.1002/jcp.21671. PubMed: 19137541.
55. Kapron JT, Hilliard GM, Lakins JN, Tenniswood MP, West KA, et al. (1997) Identification and characterization of glycosylation sites in human serum clusterin. Protein Sci 6: 2120-2133. PubMed: 9336835.
56. Urban J, Parczyk K, Leutz A, Kayne M, Kondor-Koch C, (1987) Constitutive apical secretion of an 80-kD sulfated glycoprotein complex in the polarized epithelial Madin-Darby canine kidney cell line. J Cell Biol 105: 2735-2743. doi:10.1083/jcb.105.6.2735. PubMed: 3693398.
57. Trougakos IP, Djeu JY, Gonos ES, Boothman DA, (2009) Advances and challenges in basic and translational research on clusterin. Cancer Res 69: 403-406. doi:10.1158/0008-5472.CAN-08-2912. PubMed: 19147550.
58. Choi I, Kim J, Park JY, Kang SW, (2013) Cotransin induces accumulation of a cytotoxic clusterin variant that cotranslationally rerouted to the cytosol. Exp Cell Res.
59. Orsi A, Fioriti L, Chiesa R, Sitia R, (2006) Conditions of endoplasmic reticulum stress favor the accumulation of cytosolic prion protein. J Biol Chem 281: 30431-30438. doi:10.1074/jbc.M605320200. PubMed: 16908519.
60. Vagner S, Gensac MC, Maret A, Bayard F, Amalric F, et al. (1995) Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes. Mol Cell Biol 15: 35-44. PubMed: 7799942.
61. Biamonti G, Caceres JF, (2009) Cellular stress and RNA splicing. Trends Biochem Sci 34: 146-153. doi:10.1016/j.tibs.2008.11.004. PubMed: 19208481.
62. Rüegsegger U, Leber JH, Walter P, (2001) Block of HAC1 mRNA translation by long-range base pairing is released by cytoplasmic splicing upon induction of the unfolded protein response. Cell 107: 103-114. doi:10.1016/S0092-8674(01)00505-0. PubMed: 11595189.
63. Balantinou E, Trougakos IP, Chondrogianni N, Margaritis LH, Gonos ES, (2009) Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways. Free Radic Biol Med 46: 1267-1274. doi:10.1016/j.freeradbiomed.2009.01.025. PubMed: 19353783.
64. Ling IF, Bhongsatiern J, Simpson JF, Fardo DW, Estus S, (2012) Genetics of clusterin isoform expression and Alzheimer's disease risk. PLOS ONE 7: e33923. doi:10.1371/journal.pone.0033923. PubMed: 22506010.
65. Wei L, Xue T, Wang J, Chen B, Lei Y, et al. (2009) Roles of clusterin in progression, chemoresistance and metastasis of human ovarian cancer. Int J Cancer 125: 791-806. doi:10.1002/ijc.24316. PubMed: 19391138.
66. Xue J, Lv DD, Jiao S, Zhao W, Li X, et al. (2012) pVHL mediates K63-linked ubiquitination of nCLU. PLOS ONE 7: e35848. doi:10.1371/journal.pone.0035848. PubMed: 22532874.
67. Bhutia SK, Das SK, Kegelman TP, Azab B, Dash R, et al. (2012) mda-7/IL-24 differentially regulates soluble and nuclear clusterin in prostate cancer. J Cell Physiol 227: 1805-1813. doi:10.1002/jcp.22904. PubMed: 21732348.
68. Caccamo AE, Desenzani S, Belloni L, Borghetti AF, Bettuzzi S, (2006) Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells. J Cell Physiol 207: 208-219. doi:10.1002/jcp.20561. PubMed: 16331665.
69. Roucou X, Guo Q, Zhang Y, Goodyer CG, LeBlanc AC, (2003) Cytosolic prion protein is not toxic and protects against Bax-mediated cell death in human primary neurons. J Biol Chem 278: 40877-40881. doi:10.1074/jbc.M306177200. PubMed: 12917444.
70. Essabbani A, Garcia L, Zonetti MJ, Fisco T, Pucci S, et al. (2013) Exon-Skipping Strategy by Ratio Modulation between Cytoprotective versus Pro-Apoptotic Clusterin Forms Increased Sensitivity of LNCaP to Cell Death. PLOS ONE 8: e54920. doi:10.1371/journal.pone.0054920. PubMed: 23418433.